Microphthalmia transcription factor: A sensitive and specific marker for malignant melanoma in cytologic specimens

Cancer

Volumn 93, Issue 5, 2001, Pages 337-343

  Dorvault, Christine C ^a,d   Weilbaecher, Katherine N ^a   Yee, Herman ^b   Fisher, David E ^c   Chiriboga, Luis A ^a   Xu, Ying ^c   Chhieng, David C ^b  

^a University of Alabama at Birmingham   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Cytology; HMB 45; Melanoma; Microphthalmia transcription factor; S 100

Indexed keywords

HMB 45 ANTIGEN; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MONOCLONAL ANTIBODY HMB 45; PROTEIN S 100; TRANSCRIPTION FACTOR; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOMA; CARCINOMA; CELL NUCLEUS; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EVALUATION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LYMPHOMA; MELANOMA; MESOTHELIOMA; PANCREAS ISLET CELL TUMOR; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ANTIBODIES, MONOCLONAL; DNA-BINDING PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOMA; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; NEOPLASM PROTEINS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; S100 PROTEINS; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035950377     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.9049     Document Type: Article

References (47)

1. Fine needle aspiration biopsy of metastatic melanoma: A morphologic analysis of 174 cases
2. Diagnosis of metastatic melanoma by fine needle aspiration biopsy: A clinical and pathologic correlation of 298 cases
3. Immunohistochemistry in the evaluation of melanocytic tumors
4. Cytodiagnosis of metastatic amelanotic melanomas by fine-needle aspiration biopsy: Adjunctival value of immunocytochemistry and electron microscopy
5. Use of monoclonal antibody HMB-45 in the cytologic diagnosis of melanoma
6. A panel of antibodies useful in the cytologic diagnosis of metastatic melanoma
7. An immunoperoxidase study of S-100 protein in neoplastic cells in serous effusions. Use as a marker for melanoma
8. S-100 protein-negative malignant melanoma. Fact or fiction? A light microscopic and immunohistochemical study
9. An immunoperoxidase study of S-100 protein distribution in normal and neoplastic tissues
10. Recent applications of immunoperoxidase histochemistry in human neuro-oncology. An update
11. Role of antibody to S100 protein in diagnostic pathology
12. S-100 protein expression by primary and metastatic adenocarcinomas
13. Anit-melanoma monoclonal antibody HMB-45 identifies an oncofetal glyco-conjugate associated with immature melanosomes
14. Immunohistochemical analysis of cutaneous malignant melanoma: Comparison of S-100 protein, HMB-45 monoclonal antibody and NKI/C3 monoclonal antibody
15. Recognition of malignant melanoma by monoclonal antibody HMB-45. An immunohistochemical study of 200 paraffin-embedded cutaneous tumors
16. Comparison of HMB-45 monoclonal antibody and S-100 protein in the immunohistochemical diagnosis of melanoma
17. HMB-45 positive malignant lymphoma. A case report with literature review of aberrant HMB-45 reactivity
18. Ultrastructural localization of HMB-45 binding sites
19. A monoclonal antibody specific for cells of the melanocyte lineage
20. Microphthalmia transcription factor. A sensitive and specific melanocyte marker for melanoma diagnosis
21. A gene for Waardenburg syndrome type 2 maps close to the human homologue of the microphthalmia gene at chromosome 3p12-p14.1
22. Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene
23. Microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family
24. Microphthalmia-associated transcription factor as a regulator for melanocyte-specific transcription of the human tyrosinase gene
25. Melanocyte-specific expression of the human tyrosinase promoter: Activation by the microphthalmia gene product and role of the initiator
26. Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes
27. Tyrosinase, melan-A, and KBA62 as markers for the immunohistochemical identification of metastatic amelanotic melanomas on paraffin sections
28. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanomas. Comparison with four other melanoma markers
29. Analysis of microphthalmia transcription factor expression in normal tissues and tumors, and comparison of its expression with S-100 protein, gp 100, and tyrosinase in desmoplastic malignant melanoma
30. Osteolytic bone metastasis in breast cancer
31. Bone metastases: Pathogenesis, treatment, and rationale for use of resorption inhibitors
32. The osteoclast-associated protease cathepsin K is expressed in human breast carcinoma
33. Melanoma cell adhesion molecule (Mel-CAM, CD 146) and micropthalmia transcription factor (Mitf) expression distinguish desmoplastic/sarcomatoid melanoma (DM) from morphologic mimic
34. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas
35. Tyrosinase, melan-A, and KBA62 as markers for the immunohistochemical identification of metastatic amelanotic melanomas on paraffin sections
36. A103: An anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues
37. Effusion cytology of malignant melanoma. A morphologic and immunocytochemical analysis including application of the MART-1 antibody
38. The new melanoma markers: MART-1 and melan-A
39. Expression of melan-A (MART-1) in benign melanocytic nevi and primary cutaneous malignant melanoma
40. A comparison of A103 and inhibin reactivity in adrenal cortical tumors: Distinction from hepatocellular carcinoma and renal tumors
41. Immunoreactivity for A103, an antibody to melan-A (MART-1), in adrenocortical and other steroid tumors
42. Comparison of melanoma antigen recognized by T cells (MART-1) to HMB-45: Additional evidence to support a common lineage for angiomyolipoma, lymphangiomyomatosis, and clear cell sugar tumor
43. Melanocyte associated markers A103, T311, HMB-45, and D5 in angiomyolipmas - A comparison
44. Microphthalmia transcription factor expression in renal angiomyolipoma: Further evidence of melanogenic phenotype
45. Production and characterisation of an antimelanoma monoclonal antibody KBA.62 using a new melanoma cell line reactive on paraffin wax embedded sections
46. T311 - An anti-tyrosinase monoclonal antibody for the detection of melanocytic lesions in paraffin embedded tissues